Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis-Reference-Cited by-同舟云学术

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

Published:2021-11-18 Issue:12 Volume:11 Page:
ISSN:2162-3279
Container-title:Brain and Behavior
language:en
Short-container-title:Brain and Behavior

Author:

Coll‐Martinez Clàudia¹²^ORCID,Quintana Ester²³⁴^ORCID,Salavedra‐Pont Judit¹²,Buxó Maria⁵,González‐del‐Rio Marina¹²,Gómez Immaculada²,Muñoz‐San Martín María²,Villar Luisa María⁴⁶^ORCID,Álvarez‐Bravo Gary¹²,Robles‐Cedeño René¹²³⁴,Ramió‐Torrentà Lluís¹²³⁴,Gich Jordi¹²³

Affiliation:

1. Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department Dr. Josep Trueta University Hospital and Santa Caterina Hospital Girona/Salt Spain

2. Neurodegeneration and Neuroimflammation Research Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta Salt Spain

3. Medical Sciences Department University of Girona Girona Spain

4. REEM, Multiple Sclerosis Spanish Network Instituo de Salud Carlos III Madrid Spain

5. Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta Salt Spain

6. Immunology Department Ramon y Cajal University Hospital, IRYCIS Madrid Spain

Publisher

Wiley

Subject

Behavioral Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2405

Reference33 articles.